21st.BIO Achieves GRAS Status for Innovative Dairy Protein
![21st.BIO Achieves GRAS Status for Innovative Dairy Protein](https://investorshangout.com/images/blog/ihnews-21st.BIO%20Achieves%20GRAS%20Status%20for%20Innovative%20Dairy%20Protein.jpg)
21st.BIO Achieves Self-Affirmed GRAS Status
21st.BIO has made significant strides by earning a self-affirmed Generally Recognized as Safe (GRAS) status for its animal-free beta-lactoglobulin ingredient, known as BLG Essential+™. This achievement provides customers with the ability to launch their products in the competitive U.S. market.
Accelerating Market Entry for Customers
The innovative approach of 21st.BIO allows its partners to rapidly bring products to market, achieving development to market approval in less than two years. This capability is crucial in today’s fast-paced food industry where consumer demands continually evolve.
Leading Edge Precision Fermentation Technology
21st.BIO’s technology utilizes precision fermentation processes that have been refined over decades, including techniques partly developed with Novonesis (formerly Novozymes). This advanced production method enables the creation of high-quality beta-lactoglobulin that rivals traditional dairy proteins.
Nutritional Benefits of Beta-Lactoglobulin
Beta-lactoglobulin, a dominant protein found in bovine whey, has caught the attention of food producers due to its unique nutritional profile. It boasts an impressive array of essential and branched-chain amino acids, crucial for muscle growth and overall health.
Application Versatility
The BLG Essential+™ protein is tasteless and stable, making it suitable for a variety of product formulations, including clear protein drinks, dairy alternatives, and bakery items. Customers are excited about incorporating this innovative ingredient into diverse food products such as baked goods, nutritional formulations, and active lifestyle nutrition products.
A Unique Business Model to Empower Customers
Through 21st.BIO’s comprehensive BLG program, businesses gain access to state-of-the-art production strains and pioneering fermentation techniques, which significantly streamline the commercialization process. This model not only simplifies market entry but also supports scale-up for production.
Comprehensive Support for Product Development
According to 21st.BIO co-founder and CSO Per Falholt, the company's goal is to provide clients with unmatched access to technology and expertise. CEO Thomas G. Schmidt emphasizes that 21st.BIO is committed to being a true partner, guiding clients through every stage of development, from conception to manufacturing.
Recognizing the complexities involved in product development, 21st.BIO assists its clients in navigating the journey from strain development to fermentation processes and regulatory approvals. The company remains dedicated to innovating additional proteins tailored for various industries such as food, agriculture, and more.
About 21st.BIO
Founded with the mission to democratize access to cutting-edge precision fermentation technology, 21st.BIO strives to help biotech innovations reach the market at competitive costs. The company's leadership recognized that high production costs often prevented groundbreaking bio innovations from achieving commercial success, and they aim to bridge this gap.
With its headquarters in Copenhagen, Denmark, and a dynamic R&D team at its facilities in both Copenhagen and Davis, California, 21st.BIO is on a mission to empower bio-industrial companies globally. Their focus is on advancing large-scale production in food, materials, and agricultural sectors, thus supporting a sustainable transition.
Frequently Asked Questions
What is the significance of GRAS status?
GRAS status allows food ingredients to be recognized as safe for consumption, facilitating market entry without extensive regulatory hurdles.
How does 21st.BIO support its customers?
21st.BIO provides technical expertise, access to advanced fermentation processes, and guidance through every stage of product development, ensuring client success.
What are the applications of BLG Essential+™?
BLG Essential+™ can be used in a variety of products including protein shakes, dairy alternatives, baked goods, and nutritional supplements.
How long does it typically take for a product to reach market?
With 21st.BIO’s technology and support, customers can potentially bring products to market in less than two years.
What is the mission of 21st.BIO?
21st.BIO's mission is to make cutting-edge precision fermentation accessible, helping companies turn innovative ideas into market-ready products economically.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- Investing in Dividend Stocks: Opportunities for September Success
- MUV Rental Market Forecast: Growth to $14.4 Billion by 2032
- China Merchants Fund Management Reinforces Salary Limits for Staff
- Zscaler's Revenue Forecast Falls Short Amid Cybersecurity Challenges
- Digital Neuro Biomarkers Market Set for Major Growth by 2033
- Eckoh Plc Public Disclosure: Key Information and Dealings
- Amazon's AI Investments Position it for Future Growth
- Mr. Lid Launches New Lunch Bento Boxes for Back to School
- Simulators Market Forecast to Hit USD 36 Billion by 2032
- VIS and NXP Join Forces to Launch VSMC Semiconductor Venture
- Prompt Security Unveils Groundbreaking Governance Solution for Microsoft 365
- Cloud Storage Market Growth Forecast Showcases Major Trends
- Remote Work Security Market Forecast: $322.6 Billion by 2032
- Amebocyte Lysate Market Forecast: Growth to $1.9 Billion
- Argus Launches New Prices for Heavy Canadian Crude Exports
- Auction Results for 2.25% DGB Bonds: 2026 and 2033
- KKR's Tender Offer for Fuji Soft Set to Launch Soon
- Baseus Showcases Innovative Products at 2024 IFA Expo
- atNorth Unveils Innovative Data Center with Heat Reuse Tech
- Vesper Bio's Breakthrough Phase I Results for FTD Treatment
- Viatris Launches Cash Tender Offers for Outstanding Notes
- Eurotech Unveils Generative AI Servers Optimized for NVIDIA AI
- Shanghai Updates Financial Regulations to Enhance Global Hub Status
- 21st.BIO Secures GRAS Status for Innovative Protein Ingredient
- Foreign Investors Withdraw from Asian Tech: Insights Ahead
Recent Articles
- Exploring WisdomTree's Daily Fund Prices and Net Assets
- Cloud Storage Market Growth Forecast Showcases Major Trends
- Futures Dip as Nvidia Faces Subpoena and JOLTS Data Looms
- Key Indicators to Watch Amid Market Volatility Signs
- Tesla Achieves Record Sales in China While Stock Gains Steadily
- Japan's Motegi Proposes Stimulus for Economic Recovery
- Morgan Stanley Invests in 3forge to Boost Capabilities
- New Research on Reverse Logistics by Global Fashion Agenda
- Market Turmoil: A Cautious Outlook for Investors Ahead
- Market's Biggest Challenges Ahead as Jobs Report Looms
- Upsolve Secures $4.2 Million Grant to Develop Financial Counsel
- Restaurant Brands International Inc. Announces Notes Offering Details
- Investigation Launched into Mynaric AG by Pomerantz Law Firm
- Iovance Biotherapeutics to Showcase Innovations in TIL Therapies
- Global Cell Based Assays Market Set to Reach $35.42 Billion
- Silexion Therapeutics to Showcase Innovations at Investment Conference
- ADC Therapeutics Grants Stock Options to New Employees
- Richtech Robotics Completes $21 Million Public Offering Successfully
- Wintrust Welcomes Gina Stuart as New Head of DEI Initiatives
- Pomerantz Law Firm Files Class Action Against Outset Medical, Inc.
- Earnings Reports Coming Soon: Hewlett Packard and More
- Market Insights: Key Economic Reports to Watch This Week
- Sustainable Energy: Recycling Butter Sculpture into Power
- Pomerantz Law Firm Announces Class Action Against Lifecore Biomedical
- Royce Small-Cap Trust, Inc. Announces $0.28 Distribution per Share